TIRZEPATIDE (Mounjaro®)

Clinical Indication

Treatment of adults with insufficiently controlled type 2 diabetes mellitus

Date of classification

January 2023

Grey

Not yet reviewed drugs with no traffic light recommendation so not yet approved for use in LLR.

  • New medicines, devices, appliances.
  • New indication of existing medicine.
  • New NICE TA which has not been reviewed.
  • Not been requested for review by either TAS/LPT MMC.